ANTAGGRA

Welcome to the Brand page for “ANTAGGRA”, which is offered here for Pharmaceutical compositions for use in the treatment of inflammatory diseases, atherosclerosis and arthritis, prevention and treatment of acute thrombotic events, angina, acute myocardial infarction, transient ischemic attacks, stroke, claudication,peripheral arteriothrombosis and prevention and treatment of transplant rejection;.

Its status is currently believed to be active. Its class is unavailable. “ANTAGGRA” is believed to be currently owned by “Immugen Pharmaceuticals, Inc.”